Description | FF-10101isanovelirreversIBLeFLT3inhibitorwithic50of0.20nMand0.16nMforFLT3(WT)andFLT3(D835Y),respectively. | ||||
---|---|---|---|---|---|
Targets |
| ||||
Invitro | FF-10101potentlyandselectivelyinhibitsthegrowthofmutantFLT3-expressingleukemiacellsinvitro.[1] | ||||
Invivo | OraladmiNISTrationofFF-10101showssignificantanti-leukemiceffectsat5mg/kgand10mg/kgtwicedailyfor11daysinthePDXmodelofAMLcellswithFLT3-ITD.[1] |